Hemostemix Inc (HEM : TSX-V)
Common Stock
$0.07
CAD
+0.00 (7.14%)
Last updated: 2026-09-03
Get HEM alerts:
HEM
Hemostemix Inc
WealthAwesomePerformance
1 Day
+7.14%
1 Week
-6.25%
1 Month
+25.00%
YTD
-16.67%
Key Statistics
Market Cap
$15.86M
52W High
$0.14
52W Low
$0.04
P/E Ratio
-
50 Day MA
$0.07
200 Day MA
$0.07
Beta
0.61
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/3/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 2,978 |
| 9/2/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 5,001 |
| 9/1/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 22,844 |
| 8/31/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 20,400 |
| 8/28/2026 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 0 |
| 8/27/2026 | $0.07 | $0.08 | $0.07 | $0.08 | $0.08 | 59,000 |
| 8/26/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 1,912 |
| 8/25/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 1,300 |
| 8/24/2026 | $0.07 | $0.08 | $0.07 | $0.07 | $0.07 | 113,267 |
| 8/21/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 5,629 |
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1180.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1180.0% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
103.0%
Annualized
90-Day Vol
117.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.08 | C$0.06 – C$0.11 |
| 60 trading days | C$0.08 | C$0.05 – C$0.14 |
| 90 trading days | C$0.09 | C$0.05 – C$0.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Hemostemix Inc
Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II clinical trial for the treatment of peripheral arterial disease, chronic limb threatening ischemia, cardiovascular ischemia and angina, and vascular dementia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-4.98M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.02
- Book Value
- -0.03
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About HEM
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
HEM.V news timeline
15 articles covering HEM.V, most recent first
LatestWhy Hemostemix Inc stock surged yesterday
August 2026
- Why Hemostemix Inc stock is plummeting today
- Why Hemostemix Inc stock is skyrocketing today
- Why Hemostemix Inc stock is skyrocketing today
- Why Hemostemix Inc stock plummeted yesterday
- Why Hemostemix Inc stock is skyrocketing today
- Why Hemostemix Inc stock is skyrocketing today
- Why Hemostemix Inc stock is skyrocketing today
July 2026
- Why Hemostemix Inc stock is plummeting today
- Why Hemostemix Inc stock is plummeting today
- Why Hemostemix Inc stock is skyrocketing today
- Why Hemostemix Inc stock is skyrocketing today
- Why Hemostemix Inc stock is skyrocketing today
- Why Hemostemix Inc stock is plummeting today
- Why Hemostemix Inc stock is plummeting today